These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12363064)

  • 1. The effects of antimalarial drugs on ventricular repolarization.
    Touze JE; Heno P; Fourcade L; Deharo JC; Thomas G; Bohan S; Paule P; Riviere P; Kouassi E; Buguet A
    Am J Trop Med Hyg; 2002 Jul; 67(1):54-60. PubMed ID: 12363064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac effects of antimalarial treatment with halofantrine.
    Nosten F; ter Kuile FO; Luxemburger C; Woodrow C; Kyle DE; Chongsuphajaisiddhi T; White NJ
    Lancet; 1993 Apr; 341(8852):1054-6. PubMed ID: 8096959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of antimalarial drugs and cardiomyocytes. Pathogenic approach and new therapeutic recommendations].
    Touze JE; Heno P; Fourcade L; Paule P
    Bull Acad Natl Med; 2006 Feb; 190(2):439-49; discussion 449-52. PubMed ID: 17001871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the cardiac effects of the antimalarials co-artemether and halofantrine in healthy participants.
    Bindschedler M; Lefèvre G; Degen P; Sioufi A
    Am J Trop Med Hyg; 2002 Mar; 66(3):293-8. PubMed ID: 12139223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria.
    Touze JE; Bernard J; Keundjian A; Imbert P; Viguier A; Chaudet H; Doury JC
    Am J Trop Med Hyg; 1996 Mar; 54(3):225-8. PubMed ID: 8600754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of halofantrine-induced QTc prolongation by mefloquine: correlation with blood concentrations of halofantrine.
    Lightbown ID; Lambert JP; Edwards G; Coker SJ
    Br J Pharmacol; 2001 Jan; 132(1):197-204. PubMed ID: 11156578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mefloquine versus halofantrine in children suffering from acute uncomplicated falciparum malaria].
    Minodier P; Noël G; Salles M; Retornaz K; Walters H; Combes JC; Garnier JM
    Arch Pediatr; 2005 Apr; 12 Suppl 1():S67-71. PubMed ID: 15893244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac effects of standard-dose halofantrine therapy.
    Matson PA; Luby SP; Redd SC; Rolka HR; Meriwether RA
    Am J Trop Med Hyg; 1996 Mar; 54(3):229-31. PubMed ID: 8600755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is halofantrine still advisable in malaria attacks?
    Touze JE; Fourcade L; Peyron F; Heno P; Deharo JC
    Ann Trop Med Parasitol; 1997 Oct; 91(7):867-73. PubMed ID: 9625944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac complications of halofantrine: a prospective study of 20 patients.
    Monlun E; Le Metayer P; Szwandt S; Neau D; Longy-Boursier M; Horton J; Le Bras M
    Trans R Soc Trop Med Hyg; 1995; 89(4):430-3. PubMed ID: 7570888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.
    Randrianarivelojosia M; Ratsimbasoa A; Randrianasolo L; Randrianarijaona A; Jambou R
    East Afr Med J; 2002 May; 79(5):237-41. PubMed ID: 12638806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long QTc interval complicating halofantrine therapy in 2 children with Plasmodium falciparum malaria].
    Olivier C; Rizk C; Zhang D; Jacqz-Aigrain E
    Arch Pediatr; 1999 Sep; 6(9):966-70. PubMed ID: 10519031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrocardiographic changes due to halofantrine in the treatment of malaria: therapeutic implications].
    Giudicelli CP; Touze JE; Bernard J
    Bull Acad Natl Med; 1996 Jan; 180(1):71-80; discussion 80-2. PubMed ID: 8696880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of halofantrine.
    Karbwang J; Na Bangchang K
    Clin Pharmacokinet; 1994 Aug; 27(2):104-19. PubMed ID: 7955774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with halofantrine.
    Kano S; Hayashi A; Kanda T; Suzuki M
    Kansenshogaku Zasshi; 1995 Dec; 69(12):1408-12. PubMed ID: 8586895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review.
    Haeusler IL; Chan XHS; Guérin PJ; White NJ
    BMC Med; 2018 Nov; 16(1):200. PubMed ID: 30400791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs.
    Pradines B; Rogier C; Fusai T; Tall A; Trape JF; Doury JC
    Am J Trop Med Hyg; 1998 Mar; 58(3):354-7. PubMed ID: 9546418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum.
    Basco LK; Le Bras J
    Am J Trop Med Hyg; 1992 Oct; 47(4):521-7. PubMed ID: 1443351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of cardiotoxicity of halofantrine.
    Wesche DL; Schuster BG; Wang WX; Woosley RL
    Clin Pharmacol Ther; 2000 May; 67(5):521-9. PubMed ID: 10824631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria.
    Krishna S; ter Kuile F; Supanaranond W; Pukrittayakamee S; Teja-Isavadharm P; Kyle D; White NJ
    Br J Clin Pharmacol; 1993 Dec; 36(6):585-91. PubMed ID: 12959277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.